Overall there is an increase in NAFLD which is linked with the increase of the risk factors. One of the biggest reasons for this increase is due to the lack of formal screening in people which can help reduce the number of cases https://t.co/VrWInrNsfa @mr
RT @ThomasWAA148: https://t.co/mTdVpyA8lm This article has western studies that estimate 20-30% have NAFLD. Among type 2 diabetics 40-70% N…
A multicentre Study by M. Alexander et al - https://t.co/7g39jwwH4a with the aim to determine the changes in prevalence and incidence of recorded diagnoses of NAFLD and the effect that age and sex may have on NAFLD with the condition affecting est. 20% of
The results from the databases showed that ages groups 60-69 (males) and 70-79 (females)had the highest results of NAFLD. Whereas the age groups 18-29 for both genders were the group with the lowest amount of NAFLD cases. @mridula_chopra Article link:
Who is in a risk group? There are people with diabetes, micro-and macrovascular complications, and obesity at the risk of having liver disease. But also, lifestyle and health measures make a big influence on having NAFLD🏋️♀️ https://t.co/m5vmDL5XEQ
6/Other forms of data that was extracted was their BMI, medical history, demographic and lifestyle, which was all complied to provide more information on NAFLD. https://t.co/BearCvjRyg
A research group took data from databases in Italy (HSD: Health Search Database), the Netherlands (IPCI: Integrated Primary Care Information), the UK (THIN: the health improvement network) and Spain (SIDIAP: Information System for Research in Primary Care)
A study included in a research article https://t.co/fwt9btTJq2 by Alexander, M., et al (2018), highlights under diagnosis of NAFLD. Primary care records based in the UK, Spain, Italy, and Netherlands show that out of 17,699,973 patients only 176,144 had re
As indicated by a multicenter study https://t.co/yfNJ6TKHzq. Non-alcoholic fatty liver disease (NAFLD) refers to variety of conditions caused by the presence of excess fat in the liver. Abnormal liver imaging or high serum liver enzymes are frequently used
@mridula_chopra Want to know about a diagnostic gap in non-alcoholic fatty liver disorder (NAFLD)? Keep reading. Alexander M et al (2018), Real-word data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/eSLX2d1jhS.
To find out more information about this study and in-depth statistics, visit Alexander M et al, (2018) Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/VG9xy9JyMr @mridula_chopra
Citation: Alexander, M., Loomis, A.K., Fairburn-Beech, J. et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med 16, 130 (2018). https://t.co/kzpJF1W6X7
Non-alcoholic fatty liver disease (NAFLD) is a fast-growing form of chronic liver disease around the world, with major health consequences such as heart disease, liver failure, and cancer. The following is a link to the article: https://t.co/WvTaGkKoAR Mar
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease (https://t.co/ncGxTOoUp3) This article shows that based on the overall data gathered across the world, there’s an increased prevalence and incidence diagnosis of non-alcoholic fat
A study by Alexander M et al (2018) https://t.co/iO1fByxot4 data was extracted from 4 European territories (UK, Spain, Italy and Netherlands) from 2007 - 2015, to reveal a diagnostic gap in NAFLD. Data was pooled and assessed for age and sex specific preva
NAFLD is under diagnosed as suggested by “Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease” -Alexander M et al (2018) -https://t.co/GCspbNiLuq The diagnoses were analysed for the changes in prevalence and incidence from 2007-201
https://t.co/O21rhzmbAE From the descriptive take which shows the data, some things were considered. In my opinion it wouldn’t give clear data results if they were included.
A multicentre study (Alexander M, et al (2018), Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/wvXHKnNvEF) highlighted a diagnostic gap in NAFLD suggesting under-diagnosis. But what does this all mean?
https://t.co/mTdVpyA8lm This article has western studies that estimate 20-30% have NAFLD. Among type 2 diabetics 40-70% NAFLD presence and 90% in the morbidly obese. NAFLD scaring is 3rd most common indication for a liver transplant and is expected to be t
Is there a large gap in the diagnosis stage for non-alcoholic fatty liver disease (NAFLD)? NAFLD is a spectrum of diseases caused by build-up of fat in the liver, affecting ~20% of the general population. However, there’s a vast amount of under-diagnosis(h
Overall there is an increase in NAFLD which is linked with the increase of the risk factors. One of the biggest reasons for this increase is due to the lack of formal screening in people which can help reduce the number of cases. https://t.co/VrWInrNsfa @m
Overall, the study has highlighted an increase in the trend of NAFLD incidence and predicted reasoning for this can be related to increased trends of obesity worldwide. Semantic harmonisation could be utilised in further studies. Article - https://t.co/u1s
IBMS JBL Due 1st April 2020 https://t.co/SV4mWP1VtQ Complete the test at https://t.co/W6Mhu2Wupx #cpdforbms @IBMScience #clinchem
RT @IDIAPJGol: "Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease." Alexander M, Loomis AK, Fairburn-Beech J, va…
RT @IDIAPJGol: "Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease." Alexander M, Loomis AK, Fairburn-Beech J, va…
"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease." Alexander M, Loomis AK, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, et al. @prieto_alhambra @PubMedHealth https://t.co/12pJ2hKGt5 https://t.co/ca13GS
@mattjhodgkinson @GilleighD @Protohedgehog Very interesting post! I think they went back to posting the author comments: https://t.co/gSP3Uas9UY
RT @LiverSaver: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease | BMC Medicine | Full Text | @scoopit https://…
NAFLD& NASH more and more common yet still under diagnosed by pcps. #knowyourrisk #liveradvocate
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease | BMC Medicine | Full Text | @scoopit https://t.co/769F2qrJIy
Real-world data suggest a diagnostic gap and unmet need in non-alcoholic fatty liver disease #NAFLD https://t.co/2M8VFHJT2x
Real-world data reveal a massive diagnostic gap in non-alcoholic fatty liver disease #NAFLD From the largest primary-care record study of 17.7 million adults https://t.co/sagFWSjKa2
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
RT @prieto_alhambra: Pubmed link here https://t.co/3ICCkFTaB3
RT @blizard_inst: New study of 18m European adults reveals a diagnostic gap in non-alcoholic fatty #liverdisease https://t.co/nCliSXArw6 @w…
New study of 18m European adults reveals a diagnostic gap in non-alcoholic fatty #liverdisease https://t.co/nCliSXArw6 @willalazawi
non-alcoholic fatty liver disease #NAFLD/#NASH incidence per international #EHR study is growing but lower than cohort estimates https://t.co/yLdT1NCT33 #obesity #hepatology #epidemiology
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
Pubmed link here https://t.co/3ICCkFTaB3
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. https://t.co/pyl6vtyiib
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
Congrats @WillAlazawi . This is beautiful data...
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
RT @prieto_alhambra: Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https:/…
NAFLD affects 20% of the population but remains under diagnosed by primary care physicians. Know your risk! Be an advocate for your health! #yourliveryourlife #liveradvocate
RT @hcvresearchnews: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease #NAFLD https://t.co/chuD0LIGsA
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease #NAFLD https://t.co/chuD0LIGsA
Our latest paper in BMC Medicine: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/dIsw8FkXTD # @CSMOxford @ndorms @sidiapdatabase @IMI_EMIF
RT @MannGsy: Big numbers here! Interesting to note that the coded prevalence of NAFLD is <2%. Looking forward to seeing the outcome data. @…
RT @WillAlazawi: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
Big numbers here! Interesting to note that the coded prevalence of NAFLD is <2%. Looking forward to seeing the outcome data. @Drfattyliver @IanARowe @phil_newsome7 thoughts?
Delighted to see this online. First of our papers on the epidemiology of #NAFLD combining data from millions of Europeans. Outcomes coming soon. https://t.co/md5syxRNV6
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease https://t.co/iC9p3wWQlZ
RT @BMCMedicine: NEW research: 'Real-world data reveal a diagnostic gap in non-#alcoholic fatty #liver disease'. @GSK @pfizer @erasmusmcint…
NEW research: 'Real-world data reveal a diagnostic gap in non-#alcoholic fatty #liver disease'. @GSK @pfizer @erasmusmcintl @ndorms @IDIAPJGol @harvardmed @UofGlasgow @blizard_inst https://t.co/O9y1NhOtiD